APO Research
Talk to an analyst

APO RESEARCH · REPORT

Implantable Neurostimulation Devices

Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.

Neurostimulation technology improves the life quality of those who are severely paralyzed or suffering from profound losses to various sense organs. It serves as the key part of neural prosthetics for hearing aids, artificial vision, artificial limbs, and brain-machine interfaces. In the case of neural stimulation, mostly an electrical stimulation is utilized and charge-balanced biphasic constant current waveforms of capacitive coupled charge injection approaches are adopted. Alternatively, the transcranial magnetic stimulation has been proposed as a non-invasive method in which a magnetic field causes neurostimulation.

Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson's disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.

Selected research

Industry Research

Implantable Neurostimulation Devices Industry Research Report 2026

21 December 2025118 pages

Choose your research edition.

Industry ResearchImplantable Neurostimulation Devices Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Implantable Neurostimulation Devices Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Implantable Neurostimulation Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Implantable Neurostimulation Devices Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Implantable Neurostimulation Devices Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.

Neurostimulation technology improves the life quality of those who are severely paralyzed or suffering from profound losses to various sense organs. It serves as the key part of neural prosthetics for hearing aids, artificial vision, artificial limbs, and brain-machine interfaces. In the case of neural stimulation, mostly an electrical stimulation is utilized and charge-balanced biphasic constant current waveforms of capacitive coupled charge injection approaches are adopted. Alternatively, the transcranial magnetic stimulation has been proposed as a non-invasive method in which a magnetic field causes neurostimulation.

Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson's disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.

Read the full market overview

Global Implantable Neurostimulation Devices key players include Medtronic, Boston Scientific, St. Jude Medical (Abbott), etc. Global top three manufacturers hold a share over 75%.

North America is the largest market, with a share over 80%, followed by Europe, and Asia (Ex.China), both have a share about 10 percent.

In terms of product, Spinal Cord Stimulation (SCS) is the largest segment, with a share over 55%. And in terms of application, the largest application is Pain Management, followed by Parkinson’s Disease, Epilepsy, Urinary and Fecal Incontinence, etc.

Report Scope

This report quantifies the global Implantable Neurostimulation Devices market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Implantable Neurostimulation Devices Market by Company

Medtronic

Boston Scientific

St. Jude Medical (Abbott)

LivaNova

Nevro

NeuroPace

Beijing Pins

Synapse Biomedical

Implantable Neurostimulation Devices Segment by Type

Spinal Cord Stimulation (SCS)

Gastric Electric Stimulation (GES)

Deep Brain Stimulation (DBS)

Sacral Nerve Stimulation (SNS)

Vagus Nerve Stimulation (VNS)

Others

Implantable Neurostimulation Devices Segment by Application

Pain Management

Parkinson's Disease

Urinary and Fecal Incontinence

Epilepsy

Gastroparesis

Others

Implantable Neurostimulation Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Implantable Neurostimulation Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Implantable Neurostimulation Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Implantable Neurostimulation Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Implantable Neurostimulation Devices manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Implantable Neurostimulation Devices by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Implantable Neurostimulation Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Implantable Neurostimulation Devices Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Implantable Neurostimulation Devices Sales (Units) of Manufacturers (2021-2026) Table 7. Global Implantable Neurostimulation Devices Sales Market Share by Manufacturers (2021-2026) Table 8. Global Implantable Neurostimulation Devices Revenue of Manufacturers (2021-2026) Table 9. Global Implantable Neurostimulation Devices Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Implantable Neurostimulation Devices Average Price (K USD/Unit) of Manufacturers (2021-2026) Table 11. Global Implantable Neurostimulation Devices Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Implantable Neurostimulation Devices, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Implantable Neurostimulation Devices, Product Type & Application Table 14. Global Implantable Neurostimulation Devices Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Implantable Neurostimulation Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Medtronic Company Information Table 19. Medtronic Business Overview Table 20. Medtronic Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 21. Medtronic Implantable Neurostimulation Devices Product Portfolio Table 22. Medtronic Recent Developments Table 23. Boston Scientific Company Information Table 24. Boston Scientific Business Overview Table 25. Boston Scientific Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 26. Boston Scientific Implantable Neurostimulation Devices Product Portfolio Table 27. Boston Scientific Recent Developments Table 28. St. Jude Medical (Abbott) Company Information Table 29. St. Jude Medical (Abbott) Business Overview Table 30. St. Jude Medical (Abbott) Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 31. St. Jude Medical (Abbott) Implantable Neurostimulation Devices Product Portfolio Table 32. St. Jude Medical (Abbott) Recent Developments Table 33. LivaNova Company Information Table 34. LivaNova Business Overview Table 35. LivaNova Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 36. LivaNova Implantable Neurostimulation Devices Product Portfolio Table 37. LivaNova Recent Developments Table 38. Nevro Company Information Table 39. Nevro Business Overview Table 40. Nevro Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 41. Nevro Implantable Neurostimulation Devices Product Portfolio Table 42. Nevro Recent Developments Table 43. NeuroPace Company Information Table 44. NeuroPace Business Overview Table 45. NeuroPace Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 46. NeuroPace Implantable Neurostimulation Devices Product Portfolio Table 47. NeuroPace Recent Developments Table 48. Beijing Pins Company Information Table 49. Beijing Pins Business Overview Table 50. Beijing Pins Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 51. Beijing Pins Implantable Neurostimulation Devices Product Portfolio Table 52. Beijing Pins Recent Developments Table 53. Synapse Biomedical Company Information Table 54. Synapse Biomedical Business Overview Table 55. Synapse Biomedical Implantable Neurostimulation Devices Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 56. Synapse Biomedical Implantable Neurostimulation Devices Product Portfolio Table 57. Synapse Biomedical Recent Developments Table 58. Global Implantable Neurostimulation Devices Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 59. Global Implantable Neurostimulation Devices Sales by Region (2021-2026) & (Units) Table 60. Global Implantable Neurostimulation Devices Sales Market Share by Region (2021-2026) Table 61. Global Implantable Neurostimulation Devices Sales by Region (2027-2032) & (Units) Table 62. Global Implantable Neurostimulation Devices Sales Market Share by Region (2027-2032) Table 63. Global Implantable Neurostimulation Devices Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Implantable Neurostimulation Devices Revenue Market Share by Region (2021-2026) Table 65. Global Implantable Neurostimulation Devices Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Implantable Neurostimulation Devices Revenue Market Share by Region (2027-2032) Table 67. North America Implantable Neurostimulation Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 68. North America Implantable Neurostimulation Devices Sales by Country (2021-2026) & (Units) Table 69. North America Implantable Neurostimulation Devices Sales by Country (2027-2032) & (Units) Table 70. North America Implantable Neurostimulation Devices Revenue by Country (2021-2026) & (US$ Million) Table 71. North America Implantable Neurostimulation Devices Revenue by Country (2027-2032) & (US$ Million) Table 72. Europe Implantable Neurostimulation Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 73. Europe Implantable Neurostimulation Devices Sales by Country (2021-2026) & (Units) Table 74. Europe Implantable Neurostimulation Devices Sales by Country (2027-2032) & (Units) Table 75. Europe Implantable Neurostimulation Devices Revenue by Country (2021-2026) & (US$ Million) Table 76. Europe Implantable Neurostimulation Devices Revenue by Country (2027-2032) & (US$ Million) Table 77. Asia Pacific Implantable Neurostimulation Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. Asia Pacific Implantable Neurostimulation Devices Sales by Country (2021-2026) & (Units) Table 79. Asia Pacific Implantable Neurostimulation Devices Sales by Country (2027-2032) & (Units) Table 80. Asia Pacific Implantable Neurostimulation Devices Revenue by Country (2021-2026) & (US$ Million) Table 81. Asia Pacific Implantable Neurostimulation Devices Revenue by Country (2027-2032) & (US$ Million) Table 82. South America Implantable Neurostimulation Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. South America Implantable Neurostimulation Devices Sales by Country (2021-2026) & (Units) Table 84. South America Implantable Neurostimulation Devices Sales by Country (2027-2032) & (Units) Table 85. South America Implantable Neurostimulation Devices Revenue by Country (2021-2026) & (US$ Million) Table 86. South America Implantable Neurostimulation Devices Revenue by Country (2027-2032) & (US$ Million) Table 87. Middle East and Africa Implantable Neurostimulation Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Middle East and Africa Implantable Neurostimulation Devices Sales by Country (2021-2026) & (Units) Table 89. Middle East and Africa Implantable Neurostimulation Devices Sales by Country (2027-2032) & (Units) Table 90. Middle East and Africa Implantable Neurostimulation Devices Revenue by Country (2021-2026) & (US$ Million) Table 91. Middle East and Africa Implantable Neurostimulation Devices Revenue by Country (2027-2032) & (US$ Million) Table 92. Global Implantable Neurostimulation Devices Sales by Type (2021-2026) & (Units) Table 93. Global Implantable Neurostimulation Devices Sales by Type (2027-2032) & (Units) Table 94. Global Implantable Neurostimulation Devices Sales Market Share by Type (2021-2026) Table 95. Global Implantable Neurostimulation Devices Sales Market Share by Type (2027-2032) Table 96. Global Implantable Neurostimulation Devices Revenue by Type (2021-2026) & (US$ Million) Table 97. Global Implantable Neurostimulation Devices Revenue by Type (2027-2032) & (US$ Million) Table 98. Global Implantable Neurostimulation Devices Revenue Market Share by Type (2021-2026) Table 99. Global Implantable Neurostimulation Devices Revenue Market Share by Type (2027-2032) Table 100. Global Implantable Neurostimulation Devices Price by Type (2021-2026) & (K USD/Unit) Table 101. Global Implantable Neurostimulation Devices Price by Type (2027-2032) & (K USD/Unit) Table 102. Global Implantable Neurostimulation Devices Sales by Application (2021-2026) & (Units) Table 103. Global Implantable Neurostimulation Devices Sales by Application (2027-2032) & (Units) Table 104. Global Implantable Neurostimulation Devices Sales Market Share by Application (2021-2026) Table 105. Global Implantable Neurostimulation Devices Sales Market Share by Application (2027-2032) Table 106. Global Implantable Neurostimulation Devices Revenue by Application (2021-2026) & (US$ Million) Table 107. Global Implantable Neurostimulation Devices Revenue by Application (2027-2032) & (US$ Million) Table 108. Global Implantable Neurostimulation Devices Revenue Market Share by Application (2021-2026) Table 109. Global Implantable Neurostimulation Devices Revenue Market Share by Application (2027-2032) Table 110. Global Implantable Neurostimulation Devices Price by Application (2021-2026) & (K USD/Unit) Table 111. Global Implantable Neurostimulation Devices Price by Application (2027-2032) & (K USD/Unit) Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Implantable Neurostimulation Devices Distributors List Table 115. Implantable Neurostimulation Devices Customers List Table 116. Implantable Neurostimulation Devices Industry Trends Table 117. Implantable Neurostimulation Devices Industry Drivers Table 118. Implantable Neurostimulation Devices Industry Restraints Table 119. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Implantable Neurostimulation Devices Product Image Figure 5. Global Implantable Neurostimulation Devices Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Implantable Neurostimulation Devices Market Size (2021-2032) & (US$ Million) Figure 7. Global Implantable Neurostimulation Devices Sales (2021-2032) & (Units) Figure 8. Global Implantable Neurostimulation Devices Average Price (K USD/Unit) & (2021-2032) Figure 9. Spinal Cord Stimulation (SCS) Product Image Figure 10. Gastric Electric Stimulation (GES) Product Image Figure 11. Deep Brain Stimulation (DBS) Product Image Figure 12. Sacral Nerve Stimulation (SNS) Product Image Figure 13. Vagus Nerve Stimulation (VNS) Product Image Figure 14. Others Product Image Figure 15. Pain Management Product Image Figure 16. Parkinson's Disease Product Image Figure 17. Urinary and Fecal Incontinence Product Image Figure 18. Epilepsy Product Image Figure 19. Gastroparesis Product Image Figure 20. Others Product Image Figure 21. Global Implantable Neurostimulation Devices Revenue Share by Manufacturers in 2025 Figure 22. Global Manufacturers of Implantable Neurostimulation Devices, Manufacturing Sites & Headquarters Figure 23. Global Top 5 and 10 Implantable Neurostimulation Devices Players Market Share by Revenue in 2025 Figure 24. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Global Implantable Neurostimulation Devices Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 26. Global Implantable Neurostimulation Devices Sales by Region in 2025 Figure 27. Global Implantable Neurostimulation Devices Revenue by Region in 2025 Figure 28. North America Implantable Neurostimulation Devices Market Size by Country in 2025 Figure 29. North America Implantable Neurostimulation Devices Sales Market Share by Country (2021-2032) Figure 30. North America Implantable Neurostimulation Devices Revenue Market Share by Country (2021-2032) Figure 31. United States Implantable Neurostimulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Canada Implantable Neurostimulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Mexico Implantable Neurostimulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Europe Implantable Neurostimulation Devices Market Size by Country in 2025 Figure 35. Europe Implantable Neurostimulation Devices Sales Market Share by Country (2021-2032) Figure 36. Europe Implantable Neurostimulation Devices Revenue Market Share by Country (2021-2032) Figure 37. Germany Implantable Neurostimulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. France Implantable Neurostimulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. U.K. Implantable Neurostimulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Italy Implantable Neurostimulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Russia Implantable Neurostimulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Spain Implantable Neurostimulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Netherlands Implantable Neurostimulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Switzerland Implantable Neurostimulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Sweden Implantable Neurostimulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Poland Implantable Neurostimulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Asia Pacific Implantable Neurostimulation Devices Market Size by Country in 2025 Figure 48. Asia Pacific Implantable Neurostimulation Devices Sales Market Share by Country (2021-2032) Figure 49. Asia Pacific Implantable Neurostimulation Devices Revenue Market Share by Country (2021-2032) Figure 50. China Implantable Neurostimulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Japan Implantable Neurostimulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South Korea Implantable Neurostimulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. India Implantable Neurostimulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Australia Implantable Neurostimulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Taiwan Implantable Neurostimulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Southeast Asia Implantable Neurostimulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Southeast Asia Implantable Neurostimulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. South America Implantable Neurostimulation Devices Market Size by Country in 2025 Figure 59. South America Implantable Neurostimulation Devices Sales Market Share by Country (2021-2032) Figure 60. South America Implantable Neurostimulation Devices Revenue Market Share by Country (2021-2032) Figure 61. Brazil Implantable Neurostimulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Argentina Implantable Neurostimulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Chile Implantable Neurostimulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Middle East and Africa Implantable Neurostimulation Devices Market Size by Country in 2025 Figure 65. Middle East and Africa Implantable Neurostimulation Devices Sales Market Share by Country (2021-2032) Figure 66. Middle East and Africa Implantable Neurostimulation Devices Revenue Market Share by Country (2021-2032) Figure 67. Egypt Implantable Neurostimulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. South Africa Implantable Neurostimulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. Israel Implantable Neurostimulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 70. Türkiye Implantable Neurostimulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 71. GCC Countries Implantable Neurostimulation Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 72. Global Implantable Neurostimulation Devices Sales Market Share by Type (2021-2032) Figure 73. Global Implantable Neurostimulation Devices Revenue Market Share by Type (2021-2032) Figure 74. Global Implantable Neurostimulation Devices Price (K USD/Unit) by Type (2021-2032) Figure 75. Global Implantable Neurostimulation Devices Sales Market Share by Application (2021-2032) Figure 76. Global Implantable Neurostimulation Devices Revenue Market Share by Application (2021-2032) Figure 77. Global Implantable Neurostimulation Devices Price (K USD/Unit) by Application (2021-2032) Figure 78. Implantable Neurostimulation Devices Value Chain Figure 79. Implantable Neurostimulation Devices Production Mode & Process Figure 80. Direct Comparison with Distribution Share Figure 81. Distributors Profiles Figure 82. Implantable Neurostimulation Devices Industry Opportunities and Challenges

Scope & coverage.

Types
  • Spinal Cord Stimulation (SCS)
  • Gastric Electric Stimulation (GES)
  • Deep Brain Stimulation (DBS)
  • Sacral Nerve Stimulation (SNS)
  • Vagus Nerve Stimulation (VNS)
  • Others
Applications
  • Pain Management
  • Parkinson's Disease
  • Urinary and Fecal Incontinence
  • Epilepsy
  • Gastroparesis
  • Others
Companies covered
  • Medtronic
  • Boston Scientific
  • St. Jude Medical (Abbott)
  • LivaNova
  • Nevro
  • NeuroPace
  • Beijing Pins
  • Synapse Biomedical

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Implantable Neurostimulation Devices Market Size (2021-2032)
  4. 2.2.2 Global Implantable Neurostimulation Devices Sales (2021-2032)
  5. 2.2.3 Global Implantable Neurostimulation Devices Market Average Price (2021-2032)
  6. 2.3 Implantable Neurostimulation Devices by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Spinal Cord Stimulation (SCS)
  9. 2.3.3 Gastric Electric Stimulation (GES)
  10. 2.3.4 Deep Brain Stimulation (DBS)
  11. 2.3.5 Sacral Nerve Stimulation (SNS)
  12. 2.3.6 Vagus Nerve Stimulation (VNS)
  13. 2.3.7 Others
  14. 2.4 Implantable Neurostimulation Devices by Application
  15. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  16. 2.4.2 Pain Management
  17. 2.4.3 Parkinson's Disease
  18. 2.4.4 Urinary and Fecal Incontinence
  19. 2.4.5 Epilepsy
  20. 2.4.6 Gastroparesis
  21. 2.4.7 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Implantable Neurostimulation Devices Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Implantable Neurostimulation Devices Sales (Units) of Manufacturers (2021-2026)
  3. 3.3 Global Implantable Neurostimulation Devices Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Implantable Neurostimulation Devices Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Implantable Neurostimulation Devices Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Implantable Neurostimulation Devices, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Implantable Neurostimulation Devices, Product Type & Application
  8. 3.8 Global Manufacturers of Implantable Neurostimulation Devices, Established Date
  9. 3.9 Global Implantable Neurostimulation Devices Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Medtronic
  2. 4.1.1 Medtronic Company Information
  3. 4.1.2 Medtronic Business Overview
  4. 4.1.3 Medtronic Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Medtronic Implantable Neurostimulation Devices Product Portfolio
  6. 4.1.5 Medtronic Recent Developments
  7. 4.2 Boston Scientific
  8. 4.2.1 Boston Scientific Company Information
  9. 4.2.2 Boston Scientific Business Overview
  10. 4.2.3 Boston Scientific Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Boston Scientific Implantable Neurostimulation Devices Product Portfolio
  12. 4.2.5 Boston Scientific Recent Developments
  13. 4.3 St. Jude Medical (Abbott)
  14. 4.3.1 St. Jude Medical (Abbott) Company Information
  15. 4.3.2 St. Jude Medical (Abbott) Business Overview
  16. 4.3.3 St. Jude Medical (Abbott) Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 St. Jude Medical (Abbott) Implantable Neurostimulation Devices Product Portfolio
  18. 4.3.5 St. Jude Medical (Abbott) Recent Developments
  19. 4.4 LivaNova
  20. 4.4.1 LivaNova Company Information
  21. 4.4.2 LivaNova Business Overview
  22. 4.4.3 LivaNova Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 LivaNova Implantable Neurostimulation Devices Product Portfolio
  24. 4.4.5 LivaNova Recent Developments
  25. 4.5 Nevro
  26. 4.5.1 Nevro Company Information
  27. 4.5.2 Nevro Business Overview
  28. 4.5.3 Nevro Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Nevro Implantable Neurostimulation Devices Product Portfolio
  30. 4.5.5 Nevro Recent Developments
  31. 4.6 NeuroPace
  32. 4.6.1 NeuroPace Company Information
  33. 4.6.2 NeuroPace Business Overview
  34. 4.6.3 NeuroPace Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 NeuroPace Implantable Neurostimulation Devices Product Portfolio
  36. 4.6.5 NeuroPace Recent Developments
  37. 4.7 Beijing Pins
  38. 4.7.1 Beijing Pins Company Information
  39. 4.7.2 Beijing Pins Business Overview
  40. 4.7.3 Beijing Pins Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Beijing Pins Implantable Neurostimulation Devices Product Portfolio
  42. 4.7.5 Beijing Pins Recent Developments
  43. 4.8 Synapse Biomedical
  44. 4.8.1 Synapse Biomedical Company Information
  45. 4.8.2 Synapse Biomedical Business Overview
  46. 4.8.3 Synapse Biomedical Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Synapse Biomedical Implantable Neurostimulation Devices Product Portfolio
  48. 4.8.5 Synapse Biomedical Recent Developments
5 Global Implantable Neurostimulation Devices Market Scenario by Region
  1. 5.1 Global Implantable Neurostimulation Devices Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Implantable Neurostimulation Devices Sales by Region: 2021-2032
  3. 5.2.1 Global Implantable Neurostimulation Devices Sales by Region: 2021-2026
  4. 5.2.2 Global Implantable Neurostimulation Devices Sales by Region: 2027-2032
  5. 5.3 Global Implantable Neurostimulation Devices Revenue by Region: 2021-2032
  6. 5.3.1 Global Implantable Neurostimulation Devices Revenue by Region: 2021-2026
  7. 5.3.2 Global Implantable Neurostimulation Devices Revenue by Region: 2027-2032
  8. 5.4 North America Implantable Neurostimulation Devices Market Facts & Figures by Country
  9. 5.4.1 North America Implantable Neurostimulation Devices Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Implantable Neurostimulation Devices Sales by Country (2021-2032)
  11. 5.4.3 North America Implantable Neurostimulation Devices Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Implantable Neurostimulation Devices Market Facts & Figures by Country
  16. 5.5.1 Europe Implantable Neurostimulation Devices Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Implantable Neurostimulation Devices Sales by Country (2021-2032)
  18. 5.5.3 Europe Implantable Neurostimulation Devices Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Implantable Neurostimulation Devices Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Implantable Neurostimulation Devices Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Implantable Neurostimulation Devices Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Implantable Neurostimulation Devices Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Implantable Neurostimulation Devices Market Facts & Figures by Country
  41. 5.7.1 South America Implantable Neurostimulation Devices Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Implantable Neurostimulation Devices Sales by Country (2021-2032)
  43. 5.7.3 South America Implantable Neurostimulation Devices Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Implantable Neurostimulation Devices Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Implantable Neurostimulation Devices Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Implantable Neurostimulation Devices Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Implantable Neurostimulation Devices Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Implantable Neurostimulation Devices Sales by Type (2021-2032)
  2. 6.1.1 Global Implantable Neurostimulation Devices Sales by Type (2021-2032) & (Units)
  3. 6.1.2 Global Implantable Neurostimulation Devices Sales Market Share by Type (2021-2032)
  4. 6.2 Global Implantable Neurostimulation Devices Revenue by Type (2021-2032)
  5. 6.2.1 Global Implantable Neurostimulation Devices Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Implantable Neurostimulation Devices Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Implantable Neurostimulation Devices Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Implantable Neurostimulation Devices Sales by Application (2021-2032)
  2. 7.1.1 Global Implantable Neurostimulation Devices Sales by Application (2021-2032) & (Units)
  3. 7.1.2 Global Implantable Neurostimulation Devices Sales Market Share by Application (2021-2032)
  4. 7.2 Global Implantable Neurostimulation Devices Revenue by Application (2021-2032)
  5. 7.2.1 Global Implantable Neurostimulation Devices Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Implantable Neurostimulation Devices Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Implantable Neurostimulation Devices Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Implantable Neurostimulation Devices Value Chain Analysis
  2. 8.1.1 Implantable Neurostimulation Devices Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Implantable Neurostimulation Devices Production Mode & Process
  5. 8.2 Implantable Neurostimulation Devices Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Implantable Neurostimulation Devices Distributors
  8. 8.2.3 Implantable Neurostimulation Devices Customers
9 Global Implantable Neurostimulation Devices Analyzing Market Dynamics
  1. 9.1 Implantable Neurostimulation Devices Industry Trends
  2. 9.2 Implantable Neurostimulation Devices Industry Drivers
  3. 9.3 Implantable Neurostimulation Devices Industry Opportunities and Challenges
  4. 9.4 Implantable Neurostimulation Devices Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst